Clin Mol Hepatol.
2025 Apr;31(2):615-619. 10.3350/cmh.2024.1180.
Treating systemic inflammation by transjugular intrahepatic portosystemic shunt: Editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
- Semmler G
1,2,3,4 - Balcar L1,2
- Mandorfer M1,2
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
- 2Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
- 3Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark
- 4Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
- KMID: 2566987
- DOI: http://doi.org/10.3350/cmh.2024.1180
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
- Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
- Rescue therapy for bleeding ectopic ileal varices with a transjugular intrahepatic portosystemic shunt and antegrade variceal embolization
- Transjugular intrahepatic portosystemic shunt trends in China: A brief review
- A new and improved transjugular intrahepatic portosystemic shunt (TIPS) stent graft: Controlled expansion
